Biotech entity
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Lingang Special Area, the most common co-covered peer. Pudong New Area appears in 1 tracked Biotech story from March 21, 2026.
Last mentioned: Mar 21, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Lingang Special Area, the most common co-covered peer. Pudong New Area appears in 1 tracked Biotech story from March 21, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pudong New Area. Shared-story counts are live from our verified record — not editorial picks.
Shanghai Biopharma 3.0
Shanghai launches the third phase of its high-quality development action plan.
National Future Industry Guidelines
China MIIT releases the first national framework for developing 'future industries'.
Shanghai is aggressively implementing a new 'first-class business environment' framework designed to anchor its position as the global epicenter for 'Future Life' industries. The initiative prioritizes regulatory breakthroughs in gene therapy and synthetic biology while expanding the Zhangjiang-Lingang biopharma corridor.
Source: tucsonpost.com · shanghainews.net
Pudong New Area is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
